tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Mcgarry, 4 are a HOLD (66.67%), 2 are a SELL (33.33%).
Analyst Steve Mcgarry, currently employed at HSBC, carries an average stock price target met ratio of 20.83% that have a potential upside of 8.84% achieved within 156 days.
Steve Mcgarry’s has documented 18 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 18-Feb-2022.
Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).
The best stock recommendation documented was for GSK (GLAXOSMITHKLINE PLC ADR) at 2/18/2022. The price target of $29.46 was fulfilled within 210 days with a profit of $10.9 (27.01%) receiving and performance score of 1.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 02-Feb-2023
2 months 26 days ago
(06-Jan-2026)
0/14 (0%)
$-14.94 (-44.95%)
Hold Since 15-Nov-2024
1 years 1 months 26 days ago
(06-Feb-2025)
0/16 (0%)
$-13.03 (-35.61%)
Buy Since 08-Nov-2023
$41
$-12.84 (-23.85%)
$20.29
1 years 3 months 30 days ago
(02-Dec-2024)
1/2 (50%)
$8.37 (25.65%)
192
Hold Since 12-Nov-2024
1 years 4 months 20 days ago
(12-Nov-2024)
7/8 (87.5%)
$17.4 (48.88%)
347
Hold Since 06-Nov-2021
1 years 4 months 24 days ago
(08-Nov-2024)
0/6 (0%)
$-14.45 (-42.70%)
What Year was the first public recommendation made by Steve Mcgarry?
